BLFS - BioLife Solutions, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
257.94M
Enterprise Value 3
278.74M
Trailing P/E
30.78
Forward P/E 1
33.93
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
10.51
Price/Book (mrq)
3.86
Enterprise Value/Revenue 3
11.36
Enterprise Value/EBITDA 6
80.10

Trading Information

Stock Price History

Beta (3Y Monthly) 1.35
52-Week Change 358.91%
S&P500 52-Week Change 313.25%
52 Week High 322.44
52 Week Low 39.15
50-Day Moving Average 316.60
200-Day Moving Average 317.86

Share Statistics

Avg Vol (3 month) 3174.35k
Avg Vol (10 day) 3189.68k
Shares Outstanding 520.1M
Float 14.92M
% Held by Insiders 129.78%
% Held by Institutions 142.44%
Shares Short (Oct 31, 2019) 41.98M
Short Ratio (Oct 31, 2019) 411.98
Short % of Float (Oct 31, 2019) 423.24%
Short % of Shares Outstanding (Oct 31, 2019) 49.85%
Shares Short (prior month Sep 30, 2019) 41.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 214/1
Last Split Date 3Jan 29, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 46.77%
Operating Margin (ttm)10.39%

Management Effectiveness

Return on Assets (ttm)2.44%
Return on Equity (ttm)18.98%

Income Statement

Revenue (ttm)24.53M
Revenue Per Share (ttm)1.30
Quarterly Revenue Growth (yoy)24.80%
Gross Profit (ttm)13.53M
EBITDA 3.48M
Net Income Avi to Common (ttm)11.41M
Diluted EPS (ttm)0.47
Quarterly Earnings Growth (yoy)656.80%

Balance Sheet

Total Cash (mrq)21.2M
Total Cash Per Share (mrq)1.04
Total Debt (mrq)1.54M
Total Debt/Equity (mrq)2.01
Current Ratio (mrq)6.49
Book Value Per Share (mrq)3.78

Cash Flow Statement

Operating Cash Flow (ttm)2.8M
Levered Free Cash Flow (ttm)955.28k